Physician profile

Curtis Whiting

Pulmonary Disease · Kansas City, MO

NPI 1477993921

$610.68

in general payments reported to CMS, 2019-2025

16 companies · $31.60 in 2025

The $31.60 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$91.50
Education$17.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alexion Pharmaceuticals, INC. $121.83 2021
Astrazeneca Pharmaceuticals LP $77.28 2023 Tezspire
Boehringer Ingelheim Pharmaceuticals, INC. $65.28 2020
Ucb, INC. $55.34 2019-2020
Glaxosmithkline, LLC. $48.93 2021-2022
Mylan Specialty L.P. $42.11 2022
Paratek Pharmaceuticals, INC. $32.89 2020-2022
Advanced Respiratory, INC $27.25 2020
Novartis Pharmaceuticals Corporation $21.48 2022
Regeneron Healthcare Solutions, INC. $21.37 2021
Bayer Healthcare Pharmaceuticals INC. $19.91 2022
United Therapeutics Corporation $18.34 2020
Chiesi USA, INC. $18.17 2022
Insmed, INC. $17.38 2025 Brinsupri
Verona Pharma, INC. $14.22 2025 Ohtuvayre
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Ambu INC. $8.90 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Curtis Whiting

$610.68

in general payments reported 2019-2025

Years
2019-2025
Top company
Alexion Pharmaceuticals, INC.
Context
The $31.60 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/4213280/curtis-whiting

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.